Abstract
The usual concept of nosocomial pneumonia (NP) includes pneumonias in noncritically immunosuppressed patients initiating more than 48 h after hospital admission. Due to the differences in the clinical picture, microbial patterns, diagnostic strategies and antibiotic therapy, NP is divided into three types [1]: (1) hospital-acquired pneumonia (HAP) is defined as a new infection of the lung parenchyma while the patient is hospitalised. (2) Ventilator-associated pneumonia (VAP) refers to pneumonia that arises more than 48–72 h after endotracheal intubation. By contrast, ventilator-associated tracheobronchitits (VAT) is characterised by the presence of signs of respiratory infection, such as an increase in the volume and purulence of respiratory secretions, fever and leucocytosis in patients undergoing mechanical ventilation; however, unlike VAP, radiological infiltrates suggestive of consolidation on chest X-ray are not observed. (3) Health-care-associated pneumonia (HCAP) is a recently described term referring to patients who contract pneumonia while receiving health care in an outpatient facility. In an important study, Friedman et al. [2] showed that healthcare-associated bloodstream infections are more similar to nosocomial infections than to community-acquired infections. Kollef and colleagues [3] carried out a retrospective cohort study based on a large inpatient database of 4543 patients and found that the mortality of HCAP was 19.8%, similar that of HAP (18.8%), but not to that of CAP (10%).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Niederman M, Craven D (2005) Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416
Friedman ND, Kaye KS, Stout JE et al (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797
Kollef M, Shorr A, Tabak Y et al (2005) Epidemiology and outcomes of health-care-associated pneumonia. Chest 128:3854–3862
Mehta RM, Niedermann MS (2003) Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. J Inten Care Med 18:175
Ewing S, Bauer T, Torres A (2002) Nosocomial pneumonia. Thorax 57:366–371
Moine P, Timsit JF, Lassence A et al (2002) Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study. Intensive Care Med 28:154–163
Alcon A, Fabregas N, Torres A (2005) Pathophysiology of pneumonia. Clin Chest Med 26(1):35–46
Sopena N, Sabria M; Neumos 2000 Study Group (2005) Multicenter study of hospitalacquired pneumonia in non-ICU patients. Chest 127:213–219
Cook DJ, Walter SD, Cook RJ (1998) Incidence and risk factors of ventilator associated pneumonia in critically ill patients. Ann Internal Med 129(6):433–444
Valles J, Pobo A, Garcia-Esquirol O et al (2007) Excess ICU mortality attributable to VAP: the role of early vs. late onset. Intensive Care Med 33:1363–1368
Bonten M, Kollef M, Hall J (2004) Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infectious Dis 38:1141–1149
Luna CM, Aruj P, Niederman MS et al for the GANAR group (2006) Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Res J 27:158–164
Craven D, De Rosa D, Thornton D (2002) Nosocomial pneumonia: emerging concepts in diagnosis, management and prophylaxis. Curr Op Crit Care 8:421–429
Safdar N, Crnich CJ, Maki DJ (2005) The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Resp Care 50:725–739
Torres A, El-Ebiary M, Soler N et al (1996) Stomach as a source of colonization of the respiratory tract during mechanical ventilation in association with VAP. Eur Respir J 8:1729–1735
Torres A, Serra-Batlles J, Ros E (1992) Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 116:540–543
Bonten MJM, Gaillard CA, van der Geest S et al (1995) The role of intragastric acidity and stress ulcer prophylaxis on colonization and infection in mechanically ventilated patients: a stratified, randomised, double blind study of sucralfate versus antacids. Am J Res Crit Care Med 152:1825–1834
Diaz E, Rodriguez A, Rello J (2005) Ventilator associated pneumonia: issues related to the artificial airway. Resp Care 50:900–906
Costerton JW, Cheng KJ, Geesey GG et al (1987) Bacterial biofilms in nature and disease. Annu Rev Microbiol 41:435–464
Consterton JW (1999) Introduction to biofilm. Int Antimicrob Agents 11:217–221
Gorman SP, McGovern JG, Woolfson AD et al (2001) The concomitant development of poly(vinyl chloride)-related biofilm and antimicrobial resistance in relation to ventilatorassociated pneumonia. Biomaterials 22:2741–2747
Vorachit M, Lam K, Jayanetra P, Costerton JW (1993) Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic discs to ceftazidime and co-trimoxazole. Antimicrob Agents Chemother 37:2000–2002
Koerner RJ (1997) Contribution of endotracheal tubes to the pathogenesis of ventilator-associated pneumonia. J Hosp Infect 35:83–89
Van Saene HKF, Damjanovic V, Williets T et al (1998) Pathogenesis of ventilator-associated pneumonia: is the contribution of biofilm clinically significant? J Hosp Infect 38:231–240
Feldman C, Kassel M, Cantrell J et al (1999) The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation. Eur Respir J 13:546–551
Fabregas N, Ewig S, Torres A et al (1999) Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54:867–873
Pugin J, Auckenthaler R, Mili N et al (1991) Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic ‘blind’ bronchoalveolar lavage fluid. Am Rev Respir Dis 143:1121–1129
Ibrahim EH, Ward S, Sherman G et al (2001) Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 29:1109–1115
Fartoukh M, Maitre B, Honore S et al (2003) Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med 168:173–179
Luna CM, Blancazo D, Niederman MS et al (2003) Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 31:676–682
Lipchik RJ, Kuzo RS (1996) Nosocomial pneumonia. Radiol Clin North Am 34:47–58
Gibot S, Gravoisy A, Levy B et al (2004) Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350:451–458
Duflo F, Debon R, Monneret G et al (2002) Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 96:74–79
Luyt CE, Guerin V, Combes A et al (2005) Procalcitonin kinetics as a prognistic marker of ventilator-associated pneumonia. Am J Resp Crit Care Med 171:48–53
Campell GD Jr (2000) Blinded invasive diagnostic procedures in ventilator-associated pneumonia. Chest 117:207S–211S
Koenig S, Truwit J (2006) Ventilator-associated pneumonia: diagnosis, treatment and prevention. Clin Microbiol Rev 19:637–657
Marik PE, Brown WJ (1995) A comparison of bronchoscopic vs. blind protected specimen brush sampling in patients with suspected ventilator-associated pneumonia. Chest 108:203–207
Dorca J, Manresa F, Esteban L et al (1995) Efficacy, safety, and therapeutic relevance of transthoracic aspiration with ultrathin needle in nonventilated nosocomial pneumonia. Am J Respir Crit Care Med 151:1491–1496
Klompas M (2007) Does the patient have ventilator-associated pneumonia? JAMA 297:1583–1593
Ruiz M, Torres A, Ewig S et al (2000) Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 162:119–125
Sanchez-Nieto JM, Torres A, Garcia-Cordoba F et al (1998) Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia. Am J Respir Crit Care Med 157:371–376
Solé Violán J, Arroyo J, Bordes A et al (2000) Impact of qualitative diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 28:2737–2741
Fagon JY, Chastre J, Wolff M et al (2000) Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med 132:621–630
The Canadian Critical Care Trials Group (2006) A randomised trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355:2619–2630
Torres A, De La Bellacasa JP, Xaubet A et al (1989) Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis 140:306–310
Luna CM, Vujacich P, Niederman MS et al (1997) Impact of BAL data on therapy and outcome of VAP. Chest 111:676–687
Alvarez-Lerma F; ICU-acquired Pneumonia Study Group (1996) Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 22:387–394
Kollef MH, Ward S (1998) The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 113:412–420
Iregui MS, Ward G, Sherman VJ et al (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122:262–268
Trouillet JL, Chastre A, Vuagnat ML et al (1998) Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am Rev Respir Dis 157:531–539
Rello J, Sa-Borges M, Correa H et al (1999) Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 160:608–613
Namias NL, Samiian D, Nino E et al (2000) Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. J Trauma 49:638–645
Pechere JC, Marchou B, Michea-Hamzehpour M, Auckenthaler R (1986) Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. J Antimicrob Chemother 17(Suppl A):11–18
Karchmer AW, Archer GL, Dismukes WE (1995) Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. Rev Infect Dis Suppl 3:S543–S548
Safdar N, Handelsman J, Maki DG (2004) Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4:519–527
Paul M, Uri-Silbiger I, Soares-Weiser K, Leibovici L (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328:668
Bliziotis IA, Samonis G, Vardakas KZ et al (2005) Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis 41:149–158
Cometta A, Baumgartner JD, Lew D (1994) Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmycin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother 38:1309–1313
Munckhof WJ, Grayson ML, Turnidge JD (1996) A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 37:645–663
Rello J, Diaz E (2003) Pneumonia in the intensive care unit. Crit Care Med 31:2544–2551
Chastre J, Wolff M, Fagon JY et al (2003) Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588–2598
Niederman MS (2006) De-escalation therapy in ventilator-associated pneumonia. Curr Opin Crit Care 12:452–457
Alvarez-Lerma F (2002) Neumonía relacionada con la ventilación mecánica. In: Grupo de trabajo de enfermedades infecciosas de la SEMICYUC, 1 ed. Estudio nacional de vigilancia de infección nosocomial en UCI (ENVIN-UCI), Madrid, pp 53–72
Souweine B, Veber B, Bedos JP et al (1998) Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit Care Med 26:236–244
Dennesen PJ, van der Ven AM, Kessels GH et al ( 2001) Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163:1371–1375
Micek S, Ward TS, Fraser VJ, Kollef MH (2004) A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 125:1791–1799
Rello J, Vidaur L, Sandiumenge A et al (2004) De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 32:2183–2190
Kollef MH, Morrow LE, Niederman MS et al (2006) Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 129:1210–1218
Singh N, Rogers P, Atwood CHW et al (2000) Short course empiric therapy for patients with pulmonary infiltrates in the intensive care unit. Am J Respir Crit Care Med 162:505–511
Alvarez-Lerma F, Alvarez B, Luque P et al (2006) Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study. Crit Care 10:R78
Niederman MS, Mandell LA, Anzueto A et al (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754
Mortensen EM, Restrepo M, Anzueto A, Pugh J (2004) Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 117:726–731
Campbell DG, Niederman MS, Broughton W et al (1006) Guidelines for the initial management of adults with hospital-acquired pneumonia. Am J Respir Crit Care Med 153:1711–1725
Ioanas M, Cavalcanti M, Ferrer M et al (2003) Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines. Eur Respir J 22:876–882
Soo Hoo GW, Wen YE, Nguyen TV, Goetz MB (2005) Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 128:2778–2787
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Liapikou, A., Valencia, M., Torres, A. (2008). Diagnosis and Treatment of Nosocomial Pneumonia. In: Lucangelo, U., Pelosi, P., Zin, W.A., Aliverti, A. (eds) Respiratory System and Artificial Ventilation. Springer, Milano. https://doi.org/10.1007/978-88-470-0765-9_11
Download citation
DOI: https://doi.org/10.1007/978-88-470-0765-9_11
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0764-2
Online ISBN: 978-88-470-0765-9
eBook Packages: MedicineMedicine (R0)